QUICK FUND SUMMARY
ICICI Prudential Pharma Healthcare and Diagnostics Fund Growth is an equity mutual fund managing assets worth ₹6,624.58 Cr. The current NAV is ₹43.84 as of Jul 20. It has delivered a 5-year CAGR of 15.94%. Investors can start with a minimum SIP amount of ₹100. The fund primarily holds Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Mankind Pharma Ltd. and Divi's Laboratories Ltd..
ICICI Prudential Pharma Healthcare and Diagnostics Fund Details
Fund Size | ₹6,624.58 Cr |
Type | Equity: Sectoral/Thematic |
Minimum Investment | ₹100 |
NAV (Jul 20) | ₹43.84 |
Plan Type | Regular |
Launch Date | 13 Jul 2018 |
Lock in Period | 0 days |
Plan Option | Growth |
Expense Ratio | 2.09% |
Withdrawal Charge | Exit load of 1% if redeemed within 15 days. |
ICICI Prudential Pharma Healthcare and Diagnostics Fund Holdings
Get an overview of this fund's exposure across asset classes, market cap segments, securities, credit ratings, etc.
No Data
ICICI Prudential Pharma Healthcare and Diagnostics Fund Peer Comparison
Comparison of funds that belong to the same category, based on historical returns
| Funds | 1Y Returns | 3Y CAGR | 5Y CAGR |
|---|---|---|---|
ICICI Prudential Pharma Healthcare and Diagnostics Fund | +8.20% | +24.54% | +15.94% |
SBI Healthcare Opportunities Fund | +15.16% | +23.29% | +16.70% |
DSP Healthcare Fund | +9.55% | +20.91% | +14.74% |
Nippon India Pharma Fund | +8.35% | +19.63% | +12.79% |
Returns Calculator
Monthly Investment
Time Period
Returns That Could Have Been Yours
3 years ago, had you invested:
₹3,600
You could have made a profit of:
₹1,541
Your Total Value could have reached:
₹5,141
ICICI Prudential Pharma Healthcare and Diagnostics Fund Risk Indicator
The risk of the scheme is very high
As per SEBI guidelines, we've provided a riskometer to help you gauge the potential risk level of a mutual fund, ensuring that your investments align with your financial goals and risk tolerance
FAQs on ICICI Prudential Pharma Healthcare and Diagnostics Fund
ICICI Prudential Pharma Healthcare and Diagnostics Fund is a Growth Equity mutual fund managed by ICICI Prudential Mutual Fund.
The current NAV of ICICI Prudential Pharma Healthcare and Diagnostics Fund is ₹43.84 as of Jul 20.
You can invest in ICICI Prudential Pharma Healthcare and Diagnostics Fund directly on share.market by searching for the fund, selecting your preferred mode (SIP or Lumpsum), and completing your KYC-verified investment in a few steps.
The minimum SIP amount for ICICI Prudential Pharma Healthcare and Diagnostics Fund is ₹100.
The expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics Fund is 2.09%.
ICICI Prudential Pharma Healthcare and Diagnostics Fund has an exit load as follows: exit load of 1% if redeemed within 15 days.
Short-term capital gains (STCG) on ICICI Prudential Pharma Healthcare and Diagnostics Fund are taxed at a flat rate of 20% (plus applicable surcharge and 4% health & education cess) if you redeem your units within 12 months of purchase. If you hold your units for more than 12 months, the gains are classified as Long-Term Capital Gains (LTCG) and taxed at 12.5% without indexation benefits, but only on the component of total equity capital gains that exceeds ₹1.25 Lakh in a single financial year. Gains up to ₹1.25 Lakh are tax-exempt. The information set out above is included for general information purposes only and does not constitute legal, financial or tax advice. Tax laws are complex and subject to frequent amendments by the Government of India. In view of the individual nature of the tax consequences, each investor is advised to consult his or her own tax consultant with respect to specific tax implications arising out of their participation in the mutual fund scheme.
Disclaimer: Past performance is not an indicator of future returns.
Mutual Fund investments are subject to market risks, read all scheme related documents and carefully for more information.

